Drugs / Epo Beta
last change Dec 2011 re-read 2 minutes ago

Epo Beta

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT00830609 Background Nov 2008 → Sep 2011 chronic hepatitis C virus infection Dr. Conrado Fernandez Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Epo Beta ClinicalTrials.gov intervention name — accepted as the source's own label NCT00830609
Route Subcutaneous “Epoetin β (450 IU/kg/week) SC” NCT00830609